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E-mail address: hwolosker@tx.technion.ac.il (H. WSerine racemase (SR) catalyses the synthesis of the transmitter/neuromodulator D-serine, which
plays a major role in synaptic plasticity and N-methyl D-aspartate receptor neurotoxicity. We now
report that SR is phosphorylated at Thr71 and Thr227 as revealed by mass spectrometric analysis
and in vivo phosphorylation assays. Thr71 phosphorylation was observed in the cytosolic and mem-
brane-bound SR while Thr227 phosphorylation was restricted to the membrane fraction. The Thr71
site has a motif for proline-directed kinases and is the main phosphorylation site of SR. Experiments
with a phosphorylation-deﬁcient SR mutant indicate that Thr71 phosphorylation increases SR activ-
ity, suggesting a novel mechanism for regulating D-serine production.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
D-Serine is an endogenous NMDA receptor (NMDAR) coagonist
that is required for NMDAR activation under physiological and
pathological conditions [1,2]. D-Serine is synthesized from L-serine
by the serine racemase (SR), an enzyme that is present in both neu-
ronal and glial cells, though highest levels of the enzyme are found
in neurons [2]. As an endogenous coagonist of NMDA receptors, D-
serine is required for synaptic plasticity and NMDAR neurotoxicity
[1]. SR knock-out mice exhibit decreased NMDAR responses [3]
and resistance to neurotoxic insults in vivo [4]. Furthermore, SR
knock-out mice show deﬁcits in spatial memory and behavioral
abnormalities that are relevant to schizophrenia [5].
SR activity is regulated by interacting proteins, S-nitrosylation,
and NMDAR-dependent association to the membrane [2,6]. We
have previously shown that membrane-association of SR is facili-
tated by phosphorylation of SR at Thr 227 in non-neuronal cells
[6], but the phosphorylation sites of the cytosolic SR, which consti-
tutes the most active pool of the enzyme, have not been previously
described.
In this study, we investigated the phosphorylation of SR in cells
using mass spectrometric analysis and in vivo phosphorylationchemical Societies. Published by E
MDAR, NMDA receptor; SR,
olosker).assays. We show that SR is mainly phosphorylated at Thr 71, which
activates D-serine synthesis.
2. Materials and methods
2.1. Liquid chromatography–mass spectrometry (LC–MS)
For LC–MS analysis, Hemagglutinin-tagged mouse SR (HA-SR)
was transfected in SH-SY5Y cells and both the membrane and cyto-
solic SR fractions were immunoprecipitated as previously de-
scribed [6]. The LC–MS analysis was carried out on an UltiMate
3000 LC system (Dionex) coupled to an ESI-Q-TOF mass spectrom-
eter (Q-Tof Micro, Waters), as previously described [6]. Automated
peptide identiﬁcation and annotation was performed against the
taxonomy ﬁltered (Mammalia) SwissProt database (version 56.0)
using an in-house Mascot server v2.2.03 (Matrix Sciences). All SR
peptide MS/MS spectra were manually validated.2.2. Phosphorylation of SR
In vivo phosphorylation of mouse SR was determined using
transfected HEK293 cells as described previously [7]. Brieﬂy, HA-
SR was transfected into HEK293 cells and labeled for 3 h with
0.2 mCi/ml of [32P] Pi. Subsequently, the cells were lysed in buffer
containing 20 mM Tris–HCl (pH 7.4), 300 mM NaCl, 1% Triton X-
100, 0.1% SDS, 1 mM EDTA, 20 mM NaF, 2 mM Na3VO4, 10 mMlsevier B.V. All rights reserved.
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1 lg/ml pepstatin. Finally, HA-SR was immunoprecipitated with an
anti-HA matrix, washed in buffer containing 300 mM NaCl and 1%
Triton X-100 and SR phosphorylation was monitored by SDS–PAGE
and autoradiography. In silico prediction of kinases mediating SR
phosphorylation was carried out using the following programs:
KinasePhos (http://kinasephos.mbc.nctu.edu.tw/index.php), Motif
Scan (http://scansite.mit.edu/motifscan_seq.phtml), Group-based
prediction system (http://gps.biocuckoo.org/) and NetPhosK1
(http://www.cbs.dtu.dk/services/NetPhosK/).
2.3. D-Serine synthesis
In vitro D-serine synthesis was monitored in buffer A containing
20 mM Tris–HCl (pH 8.5), 10 lM pyridoxal 50-phosphate, 0.5 mM
ATPcS, 2 mM MgCl2, 10 mM L-serine, and 20 lg/ml puriﬁed His-
tagged mouse SR as previously described [8]. For D-serine determi-
nation in cell extracts, HEK293 cells were ﬁrst transfected with
mouse HA-SR using Lipofectamine 2000 (Invitrogen). Twenty-four
hours after transfection, the cells were lyzed in buffer A supple-
mented with 0.5% Triton X-100 and 1 lM okadaic acid, and D-ser-
ine synthesis monitored as previously described [8]. For analyzing
D-serine synthesis in intact cells, D-serine concentration was mon-
itored in the culture media of transfected cells 24 h after addition
of 10 mM L-serine. When the activity of WT-SR was compared with
that of phosphorylation-deﬁcient SR mutants, D-serine synthesis
was normalized by the amount of SR in each protein extract or cell
lysate by employing Western blot and densitometry of the chemi-
luminescent signal (ImageQuant RT ECL, GE).
2.4. Materials
Okadaic acid, SB 415286, and staurosporine were purchased
from Sigma. 5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole (DRB),
PD98059, SB203580, SP600125, rapamycin, roscovitine, and wort-
mannin were purchased from EMD chemicals. BisindolylmaleimideTable 1
Tryptic peptides identiﬁed by capillary LC–MS/MS and assigned to HA-tagged mouse SR i
Positiona Sequence #
15–40 AHINIQDSIHLTPVLTSSILNQIAGR 0
41–51 NLFFKCELFQK 1
41–56 NLFFKCELFQKTGSFK 2
52–58 TGSFKIR 1
57–65 IRGALNAIR 1
66–77 GLIPDTPEEKPK 0
66–77 GLIPDpTPEEKPK 0
78–96 AVVTHSSGNHGQALTYAAK 0
97–114 LEGIPAYIVVPQTAPNCK 0
115–141 KLAIQAYGASIVYCDPSDESREKVTQR 3
116–137 LAIQAYGASIVYCDPSDESREK 1
142–198 IMQETEGILVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMVAGIAITIK 0
199–221 ALKPSVKVYAAEPSNADDCYQSK 1
206–221 VYAAEPSNADDCYQSK 0
222–241 LKGELTPNLHPPETIADGVK 1
222–241 LKGELpTPNLHPPETIADGVK 1
242–253 SSIGLNTWPIIR 0
254–268 DLVDDVFTVTEDEIK 0
269–277 YATQLVWGR 0
278–306 MKLLIEPTAGVALAAVLSQHFQTVSPEVK 1
307–339 NVCIVLSGGNVDLTSLNWVGQAERPAPYQTVSV 0
a Inclusive numbering of the residues, starting with 1 for the (untagged) N-terminal r
b Number of missed tryptic cleavage sites.
c Relative molecular masses calculated from the matched peptide sequence (monoiso
d Difference (error) between the experimental and calculated masses.
e Mascot ions score, unless the peptide was only assigned my manual validation (m.vI (Bis 1) was obtained from Alexis. [32P] Pi was obtained from Perkin
Elmer.
3. Results
In order to map the phosphorylation sites of SR, we carried out
LC–MS/MS analysis of the tryptic fragments of SR immunoprecipi-
tated from the cytosolic and the membrane fraction of SH-SY5Y
neuroblastoma cells that were transfected with mouse HA-SR
(Table 1). We found that both the cytosolic and the membrane-
bound SR are phosphorylated at Thr71 (Table 1 and Fig. 1). An
additional phosphorylation site at Thr227 was speciﬁcally detected
in the membrane-bound SR, as previously reported [6].
Phosphorylation of SR at Thr71 was conﬁrmed by in vivo label-
ing with [32P] Pi (Fig. 2). Mutation of Thr71 to Ala (T71A) decreased
SR phosphorylation by 90%, whereas mutation of Thr227 had little
effect on total levels of [32P]-SR (Fig. 2). This is in agreement to the
low level of membrane-bound SR under basal conditions (about 5–
10% of total SR) [6].
Since Thr71 seems to be the main SR phosphorylation site, we
investigated if Thr71 is important for the enzyme activity. To inves-
tigate the role of Thr71 phosphorylation, we compared the synthe-
sis of D-serine by wild-type (WT) SR and T71A mutant both in
extracts and culture media of transfected cells (Fig. 3A and B). We
found that the phosphorylation-deﬁcient mutant T71A has a 50%
lower activity when compared to the WT-SR (Fig. 3A and B). T71A
SR exhibits the same Km for the substrate L-serine (data not shown),
indicating that phosphorylation at Thr71 primarily affects the Vmax
of D-serine synthesis. As a control, we compared D-serine synthesis
fromWT-SR and T71A mutant puriﬁed from bacteria, which do not
possess mammalian-type protein kinases. Accordingly, bacterially
produced and puriﬁed T71A SR displays the same activity as the
WT-SR, demonstrating that the decrease in activity of T71A ob-
served in Fig. 3A and B is not due to non-speciﬁc changes in protein
activity or folding. This ﬁnding also ﬁts to the fact that Thr71 lies on
a very exposed position within a large loop (Fig. 4).mmunoprecipitated from transfected SH-SY5Y cells.
MCb Mr (calc)c Cytosolic SR Membrane-
bound SR
PTM
Dmd Scoree Dmd Scoree
2810.54 0.07 120 0.16 97
1472.75 0.02 52 0.08 51
1993.01 0.05 59 0.10 m.v.
807.46 0.01 n.s. 0.05 58
982.60 0.04 51 0.06 42
1322.71 0.03 74 0.06 66
1402.67 0.01 57 0.09 61 Phosphorylation of T71
1910.96 0.02 134 0.11 108
1969.03 0.01 54 0.13 58
3083.53 0.06 57 0.19 36
2471.16 0.08 128 0.15 97
5742.77 0.26 n.s. 0.04 n.s.
2540.22 0.06 n.s. 0.14 45
1816.76 0.01 61 0.11 78
2128.15 0.02 96 0.13 88
2208.12 n.d. n.d. 0.11 88 Phosphorylation of T227
1355.76 0.08 94 0.10 77
1736.84 0.05 67 0.13 m.v.
1092.57 0.08 55 0.08 48
3076.70 0.07 75 0.17 75
3542.78 0.08 21 0.23 m.v.
esidue of the intact protein.
topic masses, except for the value given in italic).
.), detected but not selected for MS/MS (n.s.) or not detected (n.d.).
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Fig. 1. SR is phosphorylated at Thr71. Annotated ESI-Q-TOF-MS/MS spectra of (A) the doubly charged monophosphorylated tryptic peptide ion (m/z 702.36) and (B) the
doubly charged non-phosphorylated tryptic peptide ion (m/z 662.36) covering positions 66–77 of mouse SR. Fragment ions labeled with an asterisk () have lost one molecule
of phosphoric acid (H3PO4) and peaks labeled with a hash symbol (#) represent internal fragment ions. Both, the phosphorylated and the non-phosphorylated form of this
peptide, were found in HA-SR puriﬁed from the cytosolic and membrane fraction of SH-SY5Y cells as well as in cytosolic HA-SR from HEK293 cells.
Fig. 2. Thr71 is the major phosphorylation site in mouse SR. HA tagged WT-SR and
different mutants were transfected into HEK293 cells. The cells were labeled by
incubation with [32P] Pi for 3 h. Subsequently, HA-SR was immunoprecipitated with
anti-HA matrix, and SR phosphorylation was revealed by SDS–PAGE followed by
autoradiography (upper panel). Lower panel depicts Coomasie blue staining of the
immunoprecipitated HA-SR. The data are representative of three experiments.
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dialyzed serum to the culture media (data not shown), indicating
that growth factors present in the serum stimulate SR phosphory-
lation and activity. In silico analysis of the phosphorylation motif
using different computer programs (see Section 2) indicates thata number of kinases may mediate Thr71 phosphorylation. The
strongest candidates are the proline-directed kinases that include
the mitogen-activated protein kinases (p38, ERK1 and JNK), glyco-
gen synthase kinase 3b (GSK3b) and cyclin-dependent kinases
(CDK1 and CDK5). Other kinases such as casein kinase II (CKII),
polo-like kinase 1 (PLK1) and mammalian target of rapamycin
(mTOR) were also identiﬁed by the in silico analysis. Therefore,
we tested several common inhibitors of these and other kinases
(Table 2). We found that in vivo SR phosphorylation was resistant
to high concentrations of inhibitors of the predicted kinases,
including non-selective kinase inhibitors, like staurosporine (Table
2).
To verify if SR phosphorylation is dynamic, we treated the cells
with okadaic acid, a phosphatase inhibitor (Table 2). We found that
okadaic acid triples the level of SR phosphorylation, indicating that
Thr71 site is regulated by phosphatases as well.
4. Discussion
D-Serine is involved in several NMDA receptor-dependent
events, such as neurotoxicity and synaptic plasticity [1–3]. We
found that D-serine synthesis is regulated by Thr71 phosphorylation
Fig. 3. Phosphorylation at Thr71 activates mouse SR activity. (A) The phosphorylation-deﬁcient T71A SR mutant displays lower activity when compared to WT-SR in extracts
obtained from transfected HEK293 cells. The values were normalized for the amounts of WT and T71A SR in the extracts monitored by Western blot and densitometry. (B) SR
T71A mutation decreases the D-serine synthesis in intact transfected HEK293 cells when compared to WT. The values were normalized for the amounts of SR in the cells
monitored by Western blot and densitometry of cell extracts. (C) Lack of effect of T71A mutation in recombinant His-tagged SR protein puriﬁed from Escherichia coli. The
results represent the average ± S.E.M. of 3–4 experiments carried out in triplicate. **P < 0.01 vs. WT. ***P < 0.001 vs. WT.
Fig. 4. Thr71 lies within an exposed loop. Position of Thr71 (red, spaceﬁll) and
Thr227 (green, spaceﬁll) within a model 3D structure of mouse SR (SWISS-MODEL
for UniProt ID Q9QZX7) that is based on the recently solved structure of rat SR (PDB
ID 3HMK).
Table 2
Effect of protein kinase and phosphatase inhibitors on SR phosphorylation in
transfected HEK293 cells.
Inhibitor Primary targets SR
phosphorylation
(% control)
SB203580, 10 lM p38 MAP kinase 90
SP600125, 20 lM c-Jun N-terminal kinases 101
PD98059, 50 lM MAP kinase kinase (MEK)
inhibitor, blocks ERK1/2
activation
107
SB415286, 50 lM Glycogen synthase kinase
3b
96
Roscovitine, 50 lM CDK1, CDK5 and other
cyclin-dependent kinases
100
Bis-1, 1 lM Protein kinase C 90
DRB, 50 lM Casein kinase II 75
Wortmannin, 100 nM Phosphatidylinositol 3-
kinase
122
Staurosporine, 1 lM Non-selective inhibitor of
Protein kinase C, PLK1 and
others
100
Rapamycin, 100 nM Mammalian target of
rapamycin complex 1
113
Okadaic acid, 1 lM Protein phosphatases (PP1
and PP2A)
309
The results are the average of three in vivo SR phosphorylation experiments.
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vealed by in vivo phosphorylation studies in transfected cells. The
role of Thr71 phosphorylation in increasing SR activity was ob-
served both in transfected cell extracts and in cell cultures by mon-
itoring D-serine concentration in the culture media (Fig. 3).
Furthermore, Thr71 phosphorylation was increased by serum addi-
tion and by phosphatase inhibition, suggesting a dynamically regu-
lated process.
We have recently reported that Thr227 phosphorylation modu-
lates SR interaction with the membrane in non-neuronal cells [6].
We now demonstrated that Thr227 phosphorylation is only pres-
ent in a minor fraction of SR that corresponds to the membrane-
bound SR [6]. This suggests that Thr71 rather than Thr227 is the
main target for phosphorylation at the mouse SR. Thr71 is not
found in the human SR, indicating that Thr71 phosphorylation
plays a species-speciﬁc role. Thus, phosphorylation of Thr71 may
regulate physiological processes that are altered in SR-KO mice,
such as long term-potentiation of synaptic activity, susceptibility
to neurotoxic insult, sociability and spatial discrimination [3–5].Other species-speciﬁc variations in SR protein seem to affect its
interaction with protein partners as the rat and bovine SR lack
the C-terminal PDZ-binding motif required for SR interaction with
Grip-1 and Pick-1 in mice [2]. Furthermore, there is evidence that
synaptic activity regulation differs in mice when compared to
other species. a-Takusan, a rodent-speciﬁc gene family composed
of dozens of variants, regulates synaptic activity in mice, but these
variants are absent in humans [9]. In this context, like a-takusan, it
is possible that Thr71 phosphorylation of SR regulates synaptic
activity in mice and may play a role in mice-speciﬁc behaviors as
well.
The mechanism by which phosphorylation increases D-serine
synthesis seems to be related to an increase in the turnover rate
of the enzyme, rather than a change in the afﬁnity to L-serine. The
identity of the kinase that phosphorylates SR was not determined
in this study, as the in vivo SR phosphorylation was unaffected by
inhibitors against all the in silico-predicted kinases. Interestingly,
the heterogeneous nuclear ribonucleoprotein D (hnRPD) is phos-
phorylated in vivo at Thr193 by an unknown kinase at a site almost
V.N. Foltyn et al. / FEBS Letters 584 (2010) 2937–2941 2941identical to the sequence surrounding SR-Thr71 (188 GLSPDpTPEEK
197) [10], indicating that SR and hnRPD might be targeted by sim-
ilar protein kinases.We recently demonstrated that NMDA receptor
overactivation provides a feedback inhibition of D-serine synthesis
[6]. It is conceivable that changes in neuronal activity may affect
SR phosphorylation as well; thereby, regulating D-serine synthesis
and NMDA receptor-dependent events.
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